KG Co Gmbh Management Tvm IV Net Worth & Insider Trades
KG Co Gmbh Management Tvm IV Enanta Pharmaceuticals Inc
What is KG Co Gmbh Management Tvm IV's Net Worth?
The current estimated net worth of Enanta Pharmaceuticals Inc's KG Co Gmbh Management Tvm IV is estimated to be about $82.1M . KG Co Gmbh Management Tvm IV owns about 1,178,534 units of Enanta Pharmaceuticals Inc common stock. In the last year at Enanta Pharmaceuticals Inc, KG Co Gmbh Management Tvm IV has sold an estimated value of $28.86M worth.
What is KG Co Gmbh Management Tvm IV's Past Insider Trading?
KG Co Gmbh Management Tvm IV's largest purchase order was 2,532,119 units , worth over $1.86M on March 28, 2013. KG Co Gmbh Management Tvm IV's largest sale order was 439,334 units , worth over $17.05M on March 5, 2014. In total, KG Co Gmbh Management Tvm IV has made about 5 transactions over a year of their time at Enanta Pharmaceuticals Inc. KG Co Gmbh Management Tvm IV usually trades in February, with the busiest year in 2014.
KG CO GMBH VENTURES SCIENCE LIFE TVM V, KG Co GmbH Management Ventures Science Life TVM V, KG CO GMBH TVM IV, KG Co GmbH Management TVM IV, KG CO GMBH VENTURES MEDICAL TVM, GmbH Capital TVM, Hubert Birner, Stefan Fischer, Alexandra Goll, HELMUT SCHUHSLER
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is KG Co Gmbh Management Tvm IV's' Mailing Address?
- Mailing address is 101 Arch Street Suite 1950 Boston MA 02210 MA
What are Enanta Pharmaceuticals Inc's Past Insider Trades?
Enanta Pharmaceuticals Inc's most recent insider trade came on March 17, 2023 by Paul Mellett who sold 10,440 units worth $463.8K . In the last 10 years, insiders at Enanta Pharmaceuticals Inc have sold an estimated value of $105.13M and bought an estimated value of $19.75M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Paul Mellett, Treasurer and CFO, Jay Luly, President and CEO, and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO .
ENANTA PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||